首页> 外文期刊>Journal of chemical information and modeling >A Simple Approach for Indexing the Oral Druglikeness of a Compound:Discriminating Druglike Compounds from Nondruglike Ones
【24h】

A Simple Approach for Indexing the Oral Druglikeness of a Compound:Discriminating Druglike Compounds from Nondruglike Ones

机译:索引化合物口服药物相似性的简单方法:区分非药物类药物中的药物类化合物

获取原文
获取原文并翻译 | 示例
           

摘要

A knowledge-based simple score has been developed for indexing the oral druglikeness of compounds based on the concept that oral druglikeness should be independent of the drug targets and,thus,are closely related to the global absorption,distribution,metabolism,and excretion related properties.We have considered several simple molecular descriptors as the key determinants of druglikeness.The patterns of the distributions of these molecular descriptors for a set of drug molecules have been extracted using a nonlinear neural network method.We assumed direct correlations of these patterns to the expectation values that a given compound may behave like a drug.On the basis of this assumption,we have defined a simple druglike index or score (DLS)combining the contributions coming from the descriptors considered.This index scales the druglikeness of a compound in the range 0.0-1.0,1.0 being the highest druglikeness.The index applied for a drug data set,a mixed data set,and three different bioactive databases produced expected features and indicated that even the marketed drugs have druglike scores varying over a considerable range.A total of 73.3% of the drugs considered showed DLS > 0.5,while it is only 44.7% for the HIC-Up compounds (unbiased ligand database).For the ChemBank,Asinex-Gold collection,and NCI databases 61.2%,76.0%,and 79.1% of the compounds have DLS > 0.5.
机译:已经开发了基于知识的简单评分,用于基于以下概念来索引化合物的口服药物相似性:口服药物相似性应独立于药物靶标,因此与总体吸收,分布,新陈代谢和排泄相关的特性密切相关我们已经考虑了几种简单的分子描述子作为确定药物相似性的关键因素。使用非线性神经网络方法提取了一组药物分子的这些分子描述子的分布模式,并假设这些模式与预期有直接关系。在此假设的基础上,我们定义了一个简单的类药物指数或评分(DLS),结合了来自所描述描述符的贡献。该指数在范围内缩放化合物的类药物性0.0-1.0,1.0为最高相似度。该索引适用于药物数据集,混合数据集和三种不同的生物活跃的数据库产生了预期的特征,并表明即使是市售的药物,其类药物分数也在相当大的范围内变化。总共考虑的73.3%的药物显示DLS> 0.5,而对于HIC-Up化合物(无偏配体)只有44.7%对于ChemBank,Ainex-Gold收集和NCI数据库,DLS> 0.5的化合物占61.2%,76.0%和79.1%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号